CRNX - Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc Logo

CRNX - Crinetics Pharmaceuticals Inc

https://www.crinetics.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.

52W High
$62.53
52W Low
$24.10
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.28
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-13.40
EV/Revenue (<3 favorable)
1585.62
P/S (TTM) (<3 favorable)
2409.20
P/B (<3 favorable)
2.86
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
2.01%
Institutions (25–75% balanced)
114.38%
Shares Outstanding
94,176,000
Float
92,780,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
1,392,000
Gross Profit (TTM)
-244,626,000
EPS (TTM)
-4.10
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-125.23%
ROE (TTM) (>15% strong)
-0.37%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
1.58
Momentum
Bearish momentum
Value
1.2182
Previous
0.9984
Trend
Rising
Signal Cross
No cross
As of
Sep. 04, 2025